Differential immuno-suppressive effects of metabolic inhibitors on T-lymphocyte activation

Eur Cytokine Netw. 1993 Mar-Apr;4(2):139-46.

Abstract

An important challenge in the field of auto-immune diseases, bone marrow and organ transplantation is the control of T-lymphocyte activation. To gain more insight into the in vitro correlation of immunosuppression, we investigated the effects of cyclosporin A (CSA) and two other metabolic inhibitors on cytokine secretion and T-cell proliferation. Secretion of TNF-alpha and GM-CSF was much more resistant to metabolic inhibitors than proliferation or synthesis of IL-1 alpha or IL-2. Moreover, our data suggested that the regulation of IL-1 alpha production in T-cells was CSA and protein kinase C (PKC)-dependent, as opposed to monocytes regulation. The receptivity to the epithelial cell-derived cytokine IL-7, associated either with antigen-dependent or independent triggering, was almost similarly inhibited by cyclosporin A, forskolin or PKC inhibitor, in sharp contrast to IL-2 receptivity. In this latter case, CD28+ IL-2 stimulation was more sensitive to both forskolin and PKC inhibition than that of CD2 or CD3+ IL-2. With regard to CSA effects, limiting dilution analysis provided evidence for some heterogeneity at the clonal level. This strongly suggested that T-cell functional monitoring at the population level does not truly reflect the actual immunosuppression. Additional experiments are required to evaluate the sensitivity to metabolic inhibitors of T-lymphocyte activation via the natural ligands of CD2 and CD28.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD
  • Antigens, Differentiation, T-Lymphocyte
  • Antimetabolites / pharmacology*
  • CD2 Antigens
  • CD28 Antigens
  • CD3 Complex
  • Colforsin / pharmacology
  • Cyclosporine / pharmacology
  • Cytokines / biosynthesis
  • Humans
  • Immunosuppressive Agents / pharmacology*
  • In Vitro Techniques
  • Indoles / pharmacology
  • Interleukin-2 / pharmacology
  • Interleukin-7 / pharmacology
  • Lymphocyte Activation / drug effects*
  • Maleimides / pharmacology
  • Protein Kinase C / antagonists & inhibitors
  • Receptors, Immunologic
  • T-Lymphocytes / drug effects*
  • T-Lymphocytes / immunology
  • T-Lymphocytes / metabolism

Substances

  • Antigens, CD
  • Antigens, Differentiation, T-Lymphocyte
  • Antimetabolites
  • CD2 Antigens
  • CD28 Antigens
  • CD3 Complex
  • Cytokines
  • Immunosuppressive Agents
  • Indoles
  • Interleukin-2
  • Interleukin-7
  • Maleimides
  • Receptors, Immunologic
  • Colforsin
  • Cyclosporine
  • Protein Kinase C
  • bisindolylmaleimide I